Metabolic Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Metabolic Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Metabolic Testing Market is likely to grow at a CAGR of 7.5% over the forecast period.

The COVID-19 pandemic is expected to have a positive impact on market growth. As per the article published in March 2021 “Pandemic effect on body composition. Single-center analysis of 2.771 cases”, the COVID-19 epidemic has resulted in an increase in sedentary lifestyles and bad dietary habits. This was caused by the essential social isolation advocated restricting the spread of SARS-CoV-2, which imposed a significant social, economic, and psychological strain. As the risk of COVID-19 contraction remains high in obese patients, the market for metabolic drugs is projected to rise. Furthermore, as a result of lockdowns and stay-at-home orders, people's lifestyles have become even more sedentary. People also have a lot more free time than they had previously. Many people use carbo-hydrated drinks and non-healthy fat because of lifestyle changes and the rising convenience of home-delivered food. With greater health consciousness, more people are choosing home workout regimens and fitness seminars. These advancements are anticipated to have an impact on the need for metabolic testing for health monitoring.

The market is primarily driven by rising in the lifestyle related diseases and growing technological advances in the metabolic testing. Growing incidence and prevalence rate of various lifestyle related diseases heart diseases, hypertension, high cholesterol, diabetes, and obesity across the world. According to the Centers for Disease Control and Prevention (CDC) data updated in July 2022, shows that coronary heart disease is the most common type of heart disease, and approximately 20.1 million adults of age 20 and older have the disease in the United States. Additionally, as per the CDC data every 40 seconds, someone suffers from a heart attack and nearly 805,000 people in the United States have a heart attack every year. Thus, the growing burden of coronary artery disease is expected to increase the demand for metabolic testing. Additionally, as per the updated May 2021 data from the World Health Organization, about 1.13 billion people around the world have hypertension, of which two-third are living in low- and middle-income countries. Thus, growing prevalence of such lifestyle diseases the demand for metabolic testing is expected to increase as growing trend towards monitor health parameters.

Many reasons are driving market growth, including a huge pool of obese patients, an increase in the prevalence of metabolic disorders, technology advancements, and rising health and fitness consciousness. For instance, in February 2022, AliveCor launched KardiaMobile Card, the slimmest, most convenient personal ECG device which fits easily into any wallet and delivers a medical-grade, single-lead ECG in 30 seconds.

Therefore, the increasing prevalence of lifestyle diseases such as cardiovascular disease, obesity, diabetes, technological advancements, and healthcare expenditure are the key driving factors in the metabolic testing market. However, high cost of Equipment and Software restrain the market growth over the forecast period.

Key Market TrendsBody Composition Analyzers Segment is Expected to Hold a Major Market Share in the Metabolic Testing Market

Body composition analyzers are devices that measure various components in the body and offer their respective values at the examination location (BCA). Body composition analyzers have numerous uses in sports and medical research, particularly causal association studies in anthropology, nutrition, epidemiology, and so on. The segment is driven by rising in the prevalence of lifestyle diseases and product launches by the key market players.

According to the World Obesity Federation's World Obesity Atlas 2022, one billion people worldwide, including one in every five women and one in every seven males, will be obese by 2030. Furthermore, because emerging countries have a larger obesity illness burden, the market for fat monitoring equipment such as body composition analyzers is likely to rise in these countries. Because of the obese population's susceptibility to lifestyle problems, sales of body composition analyzers have increased, thereby boosting the segment growth.

Furthermore, the implementation of important tactics such as mergers and acquisitions to extend the product portfolio and regional presence will fuel market growth. For instance, in April 2022, InBody has introduced the BWA 2.0 body water analyzer, which gives statistics on how body composition and body water effect wellbeing. This new professional-grade device expands on the InBody S10's outputs, which use attachable electrodes to assess body composition and body water in individuals who are immobilized or have amputated limbs.

Thu, all aforementioned factors expected to boost the segment growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global metabolic testing market due to a rise in the prevalence of lifestyle diseases such as cardiovascular diseases, obesity, and type 2 diabetes in this region. As per the Center for Diseases Control and Prevention In July 2022, over half of adults (47 percent, or 116 million) have hypertension. Thus, the growing burden of hypertension in the United States rising the demands for metabolic testing which likely to propel the growth of the market. Moreover, according to the study titled "Prevalence of overweight, obesity and central obesity and factors associated with BMI in indigenous yaqui people: a probabilistic cross-sectional survey" published in the February 2022, In Mexico, the prevalence of overweight, obesity, and central obesity was 36.5%, 35.0%, and 76.0%, respectively. This trend is more prevalent in urban areas and is projected to fuel the demand for metabolic testing in the coming years.

Furthermore, the introduction of novel items in the region leads to market expansion. For instance, in February 2022, InBody launched the BP 170 automatic blood pressure monitor, which provides individuals with the option to self-record and track key health metrics at home. Additionally, in May 2021, Lumen, a health tech firm that produced a portable metabolism assessment device, has been peer-reviewed and published in the Interactive Journal of Medical Research (I-JMR).

Hence, the aforementioned factors are expected to register significant growth in the region during the study period.

Competitive Landscape

The Metabolic Testing Market is moderately fragmented, competitive and consists of several market players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, General Electric Company, KORR Medical Technologies, Inc, CareFusion Corporation, Geratherm Medical AG, OSI Systems, Inc, AEI Technologies, Inc, Parvo Medics.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.